Literature DB >> 21112327

MicroRNA-124 suppresses oral squamous cell carcinoma motility by targeting ITGB1.

Stuart Hunt1, Adam V Jones, Emma E Hinsley, Simon A Whawell, Daniel W Lambert.   

Abstract

Alterations in the levels of molecules which interact with the extracellular matrix, such as integrins, are associated with invasion of oral squamous cell carcinomas (OSCC). The molecular mechanisms underlying dysregulation of integrin expression in OSCC, however, remain unclear. Here, we show that microRNA-124, a small non-coding RNA down-regulated in OSCC, is able to downregulate expression of integrin beta-1 (ITGB1) by interacting with its 3' untranslated region. Over-expression of miR-124 attenuates endogenous ITGB1 expression and reduces the adherence and motility of OSCC cells, suggesting disruption of miR-124-mediated repression of ITGB1 may be a key factor in OSCC progression.
Copyright © 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21112327     DOI: 10.1016/j.febslet.2010.11.038

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  69 in total

1.  miR-124 rs531564 polymorphism influences genetic susceptibility to cervical cancer.

Authors:  Henghui Wu; Juxin Zhang
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Long-Term Cigarette Smoke Exposure and Changes in MiRNA Expression and Proteome in Non-Small-Cell Lung Cancer.

Authors:  Jayshree Advani; Yashwanth Subbannayya; Krishna Patel; Aafaque Ahmad Khan; Arun H Patil; Ankit P Jain; Hitendra S Solanki; Aneesha Radhakrishnan; Sneha M Pinto; Nandini A Sahasrabuddhe; Joji K Thomas; Premendu P Mathur; Bipin G Nair; Xiaofei Chang; T S Keshava Prasad; David Sidransky; Harsha Gowda; Aditi Chatterjee
Journal:  OMICS       Date:  2017-07

3.  miRNA-124 down-regulates SOX8 expression and suppresses cell proliferation in non-small cell lung cancer.

Authors:  Chao Xie; Yunwei Han; Yi Liu; Lei Han; Jie Liu
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

4.  Deregulation of a distinct set of microRNAs is associated with transformation of gastritis into MALT lymphoma.

Authors:  Christoph Thorns; Johannes Kuba; Veronica Bernard; Andrea Senft; Silke Szymczak; Alfred C Feller; Heinz-Wolfram Bernd
Journal:  Virchows Arch       Date:  2012-03-07       Impact factor: 4.064

5.  MicroRNAs miR-25, let-7 and miR-124 regulate the neurogenic potential of Müller glia in mice.

Authors:  Stefanie G Wohl; Marcus J Hooper; Thomas A Reh
Journal:  Development       Date:  2019-09-02       Impact factor: 6.868

6.  Decrease of miR-146a is associated with the aggressiveness of human oral squamous cell carcinoma.

Authors:  Zonggao Shi; Jeffrey J Johnson; Rong Jiang; Yueying Liu; M Sharon Stack
Journal:  Arch Oral Biol       Date:  2015-06-20       Impact factor: 2.633

Review 7.  miRNAs regulate expression and function of extracellular matrix molecules.

Authors:  Zina Jeyapalan Rutnam; Thomas N Wight; Burton B Yang
Journal:  Matrix Biol       Date:  2012-11-15       Impact factor: 11.583

8.  Downregulation of microRNA-124 is an independent prognostic factor in patients with colorectal cancer.

Authors:  Mo-Jin Wang; Yuan Li; Rui Wang; Cun Wang; Yong-Yang Yu; Lie Yang; Yi Zhang; Bin Zhou; Zong-Guang Zhou; Xiao-Feng Sun
Journal:  Int J Colorectal Dis       Date:  2012-08-11       Impact factor: 2.571

9.  miR-124 Regulates the Epithelial-Restricted with Serine Box/Epidermal Growth Factor Receptor Signaling Axis in Head and Neck Squamous Cell Carcinoma.

Authors:  Manchao Zhang; Longzhu Piao; Jharna Datta; James C Lang; Xiujie Xie; Theodoros N Teknos; Anna K Mapp; Quintin Pan
Journal:  Mol Cancer Ther       Date:  2015-07-30       Impact factor: 6.261

10.  Identification of a novel miRNA-target gene regulatory network in osteosarcoma by integrating transcriptome analysis.

Authors:  Chunlei He; Hui Gao; Xiaona Fan; Maoyuan Wang; Wuyang Liu; Weiming Huang; Yadong Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.